🚀 Big milestone for Xcellbio! We’re thrilled to announce that our GMP cell therapy manufacturing platform the AVATAR Foundry has been officially installed at Fred Hutch Cancer Center in Seattle! A huge shoutout to our incredible team—Yelena Bronevetsky, PhD, Candy Garcia, and Adriana Marble—for traveling from SF to ensure a seamless setup. Your dedication is what drives our mission forward! Thanks to Tianxu Han and Peter Kim for hosting the team! This marks another step toward real-world impact, supporting patients on their journey from diagnosis to survivorship. A special thank you to the lead investigator, Dr. John Lee of UCLA for adopting the AVATAR platform to enhance the potency and persistence of STEAP1 IL18 CAR T therapy. To learn more about advanced cell therapy manufacturing visit us at xcellbio.com #avatarfoundry #carttherapy #celltherapy #cellandgenetherapy #advancedtherapies #regenerativemedicine #Lifescience #lifesciences, #biotech #biotechnology #partnerships #collaborations #strategicalliances #innovation
xcellbio’s Post
More from this author
-
PX-478, an HIF-1a inhibitor, impairs mesoCAR T cell antitumor function in cervical cancer
-
Decoding of the surfaceome and endocytome in primary glioblastoma cells identifies potential target antigens in the hypoxic tumor niche
-
Enhancing CAR-T cell metabolism to overcome hypoxic conditions in the brain tumor microenvironment.